The DNA-dependent protein kinase.
Smith
G C
GC
Wellcome/Cancer Research Campaign Institute, Cambridge, CB2 1QR, UK.
Jackson
S P
SP
D000818:Animals; D034961:Antigens, Nuclear; D004249:DNA Damage; D004265:DNA Helicases; D051747:DNA-Activated Protein Kinase; D004268:DNA-Binding Proteins / Q000378:metabolism / Q000502:physiology; D004789:Enzyme Activation; D006801:Humans; D000072200:Ku Autoantigen; D051379:Mice; D018345:Mice, Knockout; D009687:Nuclear Proteins / Q000378:metabolism / Q000502:physiology; D019869:Phosphatidylinositol 3-Kinases / Q000145:classification / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000145:classification / Q000378:metabolism*; D015398:Signal Transduction; D016615:Telomere
D034961:Antigens, Nuclear; D004265:DNA Helicases; D051747:DNA-Activated Protein Kinase; D004268:DNA-Binding Proteins; D000072200:Ku Autoantigen; D009687:Nuclear Proteins; D019869:Phosphatidylinositol 3-Kinases; D017346:Protein Serine-Threonine Kinases; C497263:PRKDC protein, human; C106893:XRCC5 protein, human; C000606509:Xrcc6 protein, human; C000606510:Xrcc6 protein, mouse